Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 51; no. 10; pp. 3612 - 3616
Main Authors Talbot, George H, Thye, Dirk, Das, Anita, Ge, Yigong
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.10.2007
Subjects
Adult
Anti-Bacterial Agents
Anti-Bacterial Agents - adverse effects
Anti-Bacterial Agents - therapeutic use
Antibiotics. Antiinfectious agents. Antiparasitic agents
Aztreonam - therapeutic use
Biological and medical sciences
Ceftaroline
Cephalosporins
Cephalosporins - adverse effects
Cephalosporins - therapeutic use
Clinical Therapeutics
Female
Humans
Male
Medical sciences
Methicillin Resistance
Middle Aged
Pharmacology. Drug treatments
Recurrence
Skin Diseases, Infectious
Skin Diseases, Infectious - drug therapy
Skin Diseases, Infectious - microbiology
Staphylococcus aureus
Streptococcus agalactiae - drug effects
Treatment Outcome
Vancomycin - therapeutic use
Infection
Treatment
Phase II trial
Complication
Skin
Structure
Comparative study
Standards
Online AccessGet full text

Cover

More Information
Summary:Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Cerexa, Inc., 1751 Harbor Bay Parkway, Alameda, CA 94502. Phone: (510) 747-3906. Fax: (510) 747-3940. E-mail: gtalbot@cerexa.com
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.00590-07